VIRP.PA
Virbac SA
Price:  
305.15 
EUR
Volume:  
3,925.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VIRP.PA WACC - Weighted Average Cost of Capital

The WACC of Virbac SA (VIRP.PA) is 6.9%.

The Cost of Equity of Virbac SA (VIRP.PA) is 7.40%.
The Cost of Debt of Virbac SA (VIRP.PA) is 4.25%.

Range Selected
Cost of equity 6.50% - 8.30% 7.40%
Tax rate 29.00% - 30.30% 29.65%
Cost of debt 4.00% - 4.50% 4.25%
WACC 6.1% - 7.8% 6.9%
WACC

VIRP.PA WACC calculation

Category Low High
Long-term bond rate 3.0% 3.5%
Equity market risk premium 5.8% 6.8%
Adjusted beta 0.6 0.63
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.50% 8.30%
Tax rate 29.00% 30.30%
Debt/Equity ratio 0.12 0.12
Cost of debt 4.00% 4.50%
After-tax WACC 6.1% 7.8%
Selected WACC 6.9%

VIRP.PA's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for VIRP.PA:

cost_of_equity (7.40%) = risk_free_rate (3.25%) + equity_risk_premium (6.30%) * adjusted_beta (0.6) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.